This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Modernatx, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Regina Fritsche-Danielson
Introduction
Regina Fritsche-Danielson is an accomplished inventor based in Mölndal, Sweden. She has made significant contributions to the field of biomedical engineering, particularly in the development of novel drug delivery systems. Her work focuses on utilizing lipid nanoparticles for therapeutic applications.
Latest Patents
One of her notable patents is titled "Lipid nanoparticles for delivering modified RNA encoding a VEGF-A polypeptide." This patent involves nanoparticles that comprise a lipid component and a modified RNA encoding a VEGF-A polypeptide. The disclosure further relates to the use of these nanoparticles for improving wound healing in subjects. Regina holds 1 patent in this area.
Career Highlights
Regina is currently associated with Modernatx, Inc., where she continues to innovate in the field of drug delivery systems. Her expertise in lipid nanoparticles has positioned her as a key player in advancing therapeutic technologies.
Collaborations
Regina has collaborated with notable colleagues such as Kenny Mikael Hansson and Kerry Benenato, contributing to a dynamic research environment that fosters innovation.
Conclusion
Regina Fritsche-Danielson's work exemplifies the intersection of technology and medicine, showcasing her commitment to improving healthcare through innovative solutions. Her contributions to the field are paving the way for future advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile